Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis

Antimicrobial Agents and Chemotherapy
Rosemary V SwansonDeepak Almeida

Abstract

The antileprosy drug clofazimine has shown potential for shortening tuberculosis treatment; however, the current dosing of the drug is not evidence based, and the optimal dosing is unknown. Our objective was to conduct a preclinical evaluation of the pharmacokinetics and pharmacodynamics of clofazimine in the mouse model of tuberculosis, with the goal of providing useful information on dosing for future studies. Pharmacokinetic parameters were evaluated in infected and uninfected BALB/c mice. Pharmacodynamic parameters were evaluated in Mycobacterium tuberculosis-infected mice that were treated for 12 weeks with one of six different clofazimine dosing regimens, i.e., doses of 6.25, 12.5, and 25 mg/kg of body weight/day and 3 regimens with loading doses. Clofazimine progressively accumulated in the lungs, livers, and spleens of the mice, reaching levels of greater than 50 μg/g in all tissues by 4 weeks of administration, while serum drug levels remained low at 1 to 2 μg/ml. Elimination of clofazimine was extremely slow, and the half-life was dependent on the duration of drug administration. Clofazimine exhibited dose-dependent tissue and serum concentrations. At any dose, clofazimine did not have bactericidal activity during the...Continue Reading

References

Oct 1, 1990·Pharmaceutical Research·A M HerreraC E Lunte
Nov 1, 1974·The American Journal of Tropical Medicine and Hygiene·D K BanerjeeM F Waters
Nov 1, 1974·The American Journal of Tropical Medicine and Hygiene·R E Mansfield
Nov 1, 1974·The American Journal of Tropical Medicine and Hygiene·L Levy
Jul 4, 2001·Clinical Pharmacokinetics·W J BurmanC Peloquin
Apr 9, 2005·Nature·Hui PanIgor Kramnik
May 6, 2010·American Journal of Respiratory and Critical Care Medicine·Armand Van DeunHans L Rieder
Sep 21, 2011·Antimicrobial Agents and Chemotherapy·Rokeya TasneenEric L Nuermberger
Dec 14, 2011·Antimicrobial Agents and Chemotherapy·Marie-Claude RouanKoen Andries
Dec 27, 2011·The Journal of Infectious Diseases·Jamie HarperSanjay K Jain
Jan 31, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·Edward A Nardell
Apr 4, 2012·Antimicrobial Agents and Chemotherapy·Kathy WilliamsEric L Nuermberger
Aug 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jacques GrossetWilliam R Bishai
Jul 5, 2013·American Journal of Respiratory and Critical Care Medicine·Jacques H GrossetArnaud Trébucq
Mar 5, 2014·Antimicrobial Agents and Chemotherapy·Ruben C HartkoornStewart T Cole
May 7, 2014·Antimicrobial Agents and Chemotherapy·Scott M IrwinAnne J Lenaerts
Jan 7, 2015·Proceedings of the National Academy of Sciences of the United States of America·Sandeep TyagiJacques H Grosset
Jan 27, 2015·American Journal of Respiratory and Critical Care Medicine·Andreas H DiaconCarl M Mendel

❮ Previous
Next ❯

Citations

Jul 26, 2015·Journal of Molecular Histology·Sooraj BaijnathThavendran Govender
Nov 2, 2016·Open Forum Infectious Diseases·Winnie SzetoMichele I Morris
Nov 1, 2016·The Journal of Antimicrobial Chemotherapy·Nicole C AmmermanJacques H Grosset
Nov 1, 2016·The Journal of Antimicrobial Chemotherapy·Moloko C CholoRonald Anderson
Aug 31, 2016·The Journal of Infectious Diseases·Dhiraj Kumar SinghGobardhan Das
Dec 23, 2016·Journal of Pharmaceutical Sciences·Julie TrexelKathleen A Stringer
Jun 1, 2017·Expert Review of Respiratory Medicine·Ignacio MonederoAdrián Sánchez-Montalvá
Aug 30, 2017·Respirology : Official Journal of the Asian Pacific Society of Respirology·Keertan DhedaChristoph Lange
May 8, 2018·Antimicrobial Agents and Chemotherapy·Nicole C AmmermanJacques H Grosset
Mar 2, 2016·Antimicrobial Agents and Chemotherapy·Rosemary V SwansonJacques H Grosset
Jul 25, 2019·Pharmaceutics·Brandon Banaschewski, Thomas Hofmann
Mar 4, 2020·Antimicrobial Agents and Chemotherapy·Alan FarajUlrika S H Simonsson
Jun 2, 2020·Future Microbiology·Niccolò RiccardiAntonio Di Biagio
May 21, 2020·The European Respiratory Journal·Fatma KortNicolas Veziris
Jul 17, 2019·Journal of the Pediatric Infectious Diseases Society·Felice C Adler-ShohetAntonio Arrieta
Jun 26, 2015·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Rahul K KeswaniGus R Rosania
Mar 6, 2019·Frontiers in Pharmacology·Lloyd TannerLubbe Wiesner
Aug 5, 2020·The Journal of Antimicrobial Chemotherapy·Mahmoud Tareq AbdelwahabPaolo Denti
Mar 24, 2017·The Journal of Antimicrobial Chemotherapy·Joseph S CavanaughUNKNOWN Global PETTS Investigators
Jan 29, 2021·Frontiers in Cellular and Infection Microbiology·Erik J HasenoehrlMichael Berney
Mar 7, 2021·Clinical Pharmacokinetics·Marieke G G SturkenboomJan-Willem C Alffenaar
Apr 10, 2020·ACS Infectious Diseases·Toni A NagyCorrella S Detweiler
Apr 28, 2020·Biochemical Pharmacology·Joseph George
Oct 6, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Phoebe C I NgSimon M Y Lee
Jun 22, 2021·Journal of Global Antimicrobial Resistance·Bahareh HajikhaniMehid Mirsaeidi
Oct 20, 2017·Molecular Pharmaceutics·Ashlee D BrunaughHugh D C Smyth
May 30, 2019·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Brandon BanaschewskiThomas Hofmann
Sep 5, 2021·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·L H CameronF Ruiz
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Kiran PatilGaurav Saraogi
Jul 20, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Reza MirnejadDavood Darban-Sarokhalil

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.